K030452

Substantially Equivalent

BAYER LIGAND PLUS 1, 2, 3 CONTROLS

Applicant: Bayer Diagnostics Corp.
Product code: JJY
Advisory panel: Clinical Chemistry
Date received: 2003-02-11
Decision date: 2003-03-03
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.